  Research articleSerum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterningXing Zhang2,3 1Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China 2Department of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China 3State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China
BMC Cancer 2007, 7:235doi:10.1186/1471-2407-7-235
Additional filesAdditional file 1: Supplemental figure 1 showing nine protein biomarkers in serum for detection of DLBCL. Mass spectra of serum samples from two different DLBCL patients (Tumor1 and Tumor2) and two nontumor control (Ctrl-1 and Ctrl-2). The average molecular mass of the nine proteins identified to be unique or overexpressed in the tumor specimens are: 2821 Da, 2954 Da, 3266 Da, 4779 Da, 5638 Da, 5707 Da, 5838 Da, 5907 Da, and 7975 Da (arrow). Format: TIFF Size: 123KB Download file Additional file 2: Supplemental figure 2 showing seven serum peaks in mass pattern for diagnosis of SELDI. Mass spectra of serum samples from two different DLBCL patients (Tumor1 and Tumor2) and two nontumor control (Ctrl-1 and Ctrl-2). The average molecular mass of the four proteins identified to be unique or overexpressed in the Ctrl specimens are: 2091 Da, 3960 Da, 4872 Da, and 14133 Da; the three DLBCL-associated proteins as listed in tumor specimens: 2503 Da, 5251 Da, and 5814 Da (arrow). Format: TIFF Size: 126KB Download file |
|
|
|
 |  | Log on / register Feedback | Support | My details |
on Google Scholar
author email
corresponding author email|
|
| © 1999-2008 BioMed Central Ltd unless otherwise stated |